PHARMACY

NCPA announces keynote speakers for Annual Convention
Peter Lovatt and Marty Makary are the keynote speakers for NCPA's annual convention in October.
Lupin receives FDA nod for 2 generics
Generic Nascoba is a vitamin B12 supplement, while generic Tivicay is used to treat HIV-1 infection.

FDA grants traditional approval for Leqembi for the treatment of Alzheimer's disease

Leqembi is the only approved treatment shown to reduce the rate of disease progression in adults with Alzheimer's, the company said.
Perrigo obtains FDA OK for Opill OTC daily oral contraceptive

Opill is the first-ever birth control pill available over the counter in the United States.
Sponsored

Healthcare Equity and Access Demands Pharmacists as Providers

Join us for a webinar focused on the quest for more affordable care taking place Aug. 22.
CVS Caremark, GoodRx launch Caremark Cost Saver program

The prescription drug discount solution aims to help lower costs for tens of millions of CVS Caremark clients' members.
Amneal launches authorized generic of Xyrem

Generic Zyrem is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness in patients aged 7 years old and older with narcolepsy.
Hikma launches Midazolam in sodium chloride injection bags

The product is indicated for continuous intravenous infusion for sedation of intubated and mechanically ventilated adults and other situations.
Despite challenges, generics companies predict a rosy future

Drug Store News is highlighting the standout generics brands that are going the extra mile in the face of challenges in the drug market.
7 companies are rolling out Humira biosimilars

Boehringer Ingelheim, Organon and Samsung Bioepis together, Sandoz, Fresenius Kabi, Celltrion USA, Coherus and Biocon Biologics have released biosimilars of AbbVie's Humira.